(Q41481880)

1 October 2017

1 reference

title

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer (English)

1 reference

1 October 2017

B S Katzenellenbogen

1 reference

1 October 2017

M M Montano

1 reference

1 October 2017

K Ekena

1 reference

1 October 2017

M E Herman

1 reference

1 October 2017

E M McInerney

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Breast Cancer Research and Treatment

1 October 2017

published in

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

23-38

1 reference

William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Endocrine pharmacology of antiestrogens as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Estrogen receptors: bioactivities and interactions with cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: insights concerning relationships among estrogen, dopamine, and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

11 beta-Amidoalkoxyphenyl estradiols, a new series of pure antiestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

The future of new pure antiestrogens in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Transcription activation by estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

BRCA1 is secreted and exhibits properties of a granin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Interaction of proteins with transcriptionally active estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Estrogen receptor variants in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Identification of a variant form of the human estrogen receptor with an amino acid replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Estrogen receptor mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Truncated forms of DNA-binding estrogen receptors in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma. vs

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Cyclic AMP binding proteins and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Relationship of cyclic AMP binding capacity and estrogen receptor to hormone sensitivity in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

Antiestrogens: mechanisms and actions in target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Biology and mode of action of pure antioestrogens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Characterization and regulation of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Elevated cyclic AMP levels in human breast-cancer tissue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005835428423

7 January 2021

Identifiers

DOI

10.1023/A:1005835428423

1 reference

Dimensions Publication ID

1 October 2017

1043959136

0 references

1 reference